Browse > Home / Drug News / Zenpep Approved for Pancreatic Disorder

Zenpep Approved for Pancreatic Disorder

August 29, 2009

Zenpep Approved for Pancreatic Disorder

Makes up on this account that lack of digestive enzymes

Exocrine pancreatic deficiency (EPI) is caused through a insufficiency of digestive enzymes produced by the pancreas, a possible indication of conditions including cystic fibrosis and pancreatic cancer.

Zenpep was approved in different strengths for adults and children as young as a year old, Eurand said in a news release. It’s expected to subsist available at U.S. pharmacies later this year.

The most common contrary reactions reported during clinical testing of Zenpep included gastrointestinal problems, abdominal pain, headache, cough and loss of weight, the company said.

More information

Learn to a greater degree about this drug’sitting approval recital from the FDA.

Written by Samanta · Filed Under Drug News